ReviewPlants (Basel, Switzerland)2025
Secondary Somatic Embryogenesis in Plants: From Cellular Mechanisms to Biotechnological Potential.
Review in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Genome degradation in plant tissue culture.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Secondary somatic embryogenesis (SSE) is a powerful tool in plant biotechnology, enabling the continuous production of embryos from primary somatic embryos (PSEs) and offering broad applications across agriculture, forestry, horticulture, and pharmaceutical industries. Depending on culture conditions, SSE may proceed directly from the surface of PSEs or indirectly via callus formation, with the outcome strongly influenced by exogenous plant growth regulators (PGRs). A key advantage of SSE is its cyclic nature, which offers a valuable strategy to maintain embryogenic potential over extended culture periods, generating true-to-type embryos without reliance on the original explant, while significantly increasing the multiplication rate, often making SSE more productive than PSE in many species. This review explores in detail the cellular origin and developmental pathways of secondary embryos, the maintenance of embryogenic competence through cyclic embryogenesis, as well as genetic and epigenetic aspects and the biotechnological applications of this process. Moreover, it addresses challenges regarding strong genotype dependence, variability in embryo quality and morphology, limitations in maturation and conversion potential, and the gradual decline of embryogenic competence with successive cycles, all of which need to be overcome to ensure the stability and reproducibility of SSE and maximize its impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.